Skip to main content
Ulrich Steidl, MD, Oncology, Bronx, NY

Ulrich Steidl MD

Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology


Physician

Join to View Full Profile
  • 1300 Morris Park AvenueBronx, NY 10461

Dr. Steidl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Heidelberg Faculty of Medicine
    University of Heidelberg Faculty of MedicineClass of 2000

Publications & Presentations

PubMed

Abstracts/Posters

  • SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML
    Ulrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical ALK5 Inhibitor, Vactosertib, Reverses TGF_-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS
    Ulrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster
    Ulrich G. Steidl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Friday Scientific Workshop on Myeloid Development 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Distinguished Cancer and Stem Cell Biologist Ulrich Steidl, M.D., Ph.D., Appointed Chair of Cell Biology at Albert Einstein College of Medicine
    Distinguished Cancer and Stem Cell Biologist Ulrich Steidl, M.D., Ph.D., Appointed Chair of Cell Biology at Albert Einstein College of MedicineNovember 22nd, 2022
  • 8 Oncologists on the Move
    8 Oncologists on the MoveApril 4th, 2022
  • NCI-Designated Albert Einstein Cancer Center Announces Major Leadership Changes
    NCI-Designated Albert Einstein Cancer Center Announces Major Leadership ChangesMarch 30th, 2022
  • Join now to see all

Grant Support

  • Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic TargetingALBERT EINSTEIN COLLEGE OF MEDICINE2021–2028
  • Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic TargetingALBERT EINSTEIN COLLEGE OF MEDICINE2021–2028
  • Contribution of macrophages in the HSC nicheALBERT EINSTEIN COLLEGE OF MEDICINE2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: